This summary was created by AI, based on 4 opinions in the last 12 months.
HCA Healthcare (HCA-N) has been recommended as a top pick by multiple experts, benefiting from the bounce back in medical procedures after Covid. It has managed the pandemic turmoil better than other hospital operators in the US. However, HCA recently reported a shocking top and bottom line miss, causing a 13% drop in the past week. Despite this, experts still believe it is progressing well and have a positive outlook on its future. HCA trades at 18x earnings and management has been aggressively buying back shares and retiring debt.
He's been recommending this post-Covid, because it's been benefitting from the huge bounce back in medical procedures that were delayed. HCA just made a new all-time high. But last Friday it reported a shocking top and bottom line miss. Is down 13% in the past week, but this is an opportunity. HCA missed only slightly, not the end of the world. Hurricanes hit revenues by $200-300 million and 60-90 cents per share, a one-off impact. HCA reaffirmed its full-year forecast, though
It is the largest hospital operator in the U.S. It is a defensive stock with consistent revenue but not consistent costs. It will continue to have issues with this and he wants to see more visibility on costs. It executes well.
(A Top Pick Aug 13/15. Down 11.51%.) This has been dead quiet over the course of the last year. It had a lift through November-February, and then basically has consolidated ever since. The group is actually starting to look quite interesting. The sector has been improving from a relative strength standpoint, since June. This could still be a Buy at these levels.
Healthcare has been a big focus of his. This is the largest hospital management companies in the US, even if only 5% of the market, so there is lots of room for growth. The US population is aging. This is a steady, non-economically sensitive company.
HCA Healthcare is a American stock, trading under the symbol HCA-N on the New York Stock Exchange (HCA). It is usually referred to as NYSE:HCA or HCA-N
In the last year, 3 stock analysts published opinions about HCA-N. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for HCA Healthcare.
HCA Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for HCA Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered HCA Healthcare In the last year. It is a trending stock that is worth watching.
On 2024-11-21, HCA Healthcare (HCA-N) stock closed at a price of $332.24.
Our PAST TOP PICK with HCA has triggered its stop at $373. To remain disciplined, we recommend covering the position at this time.